Yoshitomo Morinaga

This study evaluates the anti-biofilm activity of beta-lactam antibiotics against Pseudomonas aeruginosa biofilms formed in medium with adult bovine serum.

This study evaluates the in vivo efficacy of fidaxomicin against a rpoB mutant strain of C. difficile and finds it remains effective despite reduced susceptibility.

This study shows that anaerobic gut bacteria reduce colonization by ESBL-producing E. coli in mice, with antibiotic treatments altering this resistance.

The paper predicts SARS-CoV-2 infectivity using a mathematical model combining molecular docking simulations and phylogenetic analysis of spike protein variants.

The paper predicts that the SARS-CoV-2 BA.2.75 variant has higher infectivity than previous variants due to increased spike protein evolutionary distance and docking affinity with ACE2.